GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Goodwill-to-Asset

4d pharma (4d pharma) Goodwill-to-Asset : 0.21 (As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. 4d pharma's Goodwill for the quarter that ended in Dec. 2021 was $12.18 Mil. 4d pharma's Total Assets for the quarter that ended in Dec. 2021 was $57.10 Mil. Therefore, 4d pharma's Goodwill to Asset Ratio for the quarter that ended in Dec. 2021 was 0.21.


4d pharma Goodwill-to-Asset Historical Data

The historical data trend for 4d pharma's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Goodwill-to-Asset Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Goodwill-to-Asset
Get a 7-Day Free Trial 0.12 0.18 0.31 0.27 0.21

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 - 0.27 - 0.21

Competitive Comparison of 4d pharma's Goodwill-to-Asset

For the Biotechnology subindustry, 4d pharma's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4d pharma's Goodwill-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where 4d pharma's Goodwill-to-Asset falls into.



4d pharma Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

4d pharma's Goodwill to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Goodwill to Asset (A: Dec. 2021 )=Goodwill/Total Assets
=12.181/57.101
=0.21

4d pharma's Goodwill to Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

Goodwill to Asset (Q: Dec. 2021 )=Goodwill/Total Assets
=12.181/57.101
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4d pharma  (OTCPK:LBPWQ) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


4d pharma Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of 4d pharma's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma (4d pharma) Business Description

Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (4d pharma) Headlines

From GuruFocus

4D Pharma to Present at Upcoming Investor Conferences in March

By Business Wire Business Wire 03-03-2021

4D pharma to Present at the H.C. Wainwright BioConnect Conference

By Business Wire Business Wire 01-05-2022

4D pharma Announces Passing of Chief Financial Officer John Beck

By Business Wire Business Wire 07-26-2021

Update on Suspension of Trading

By Business Wire Business Wire 06-24-2022